| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1161/01.RES.83.12.1182 |
| P698 | PubMed publication ID | 9851935 |
| P2093 | author name string | Matsubara H | |
| P433 | issue | 12 | |
| P921 | main subject | circulatory system | Q11068 |
| pathophysiology | Q1135939 | ||
| P304 | page(s) | 1182-1191 | |
| P577 | publication date | 1998-12-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases | |
| P478 | volume | 83 |
| Q48667990 | A new transgenic rat model overexpressing the angiotensin II type 2 receptor provides evidence for inhibition of cell proliferation in the outer adrenal cortex |
| Q30421609 | A nonpeptide angiotensin II type 2 receptor agonist does not attenuate postmyocardial infarction left ventricular remodeling in mice |
| Q24634320 | A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy |
| Q45746843 | AGTR2 gene polymorphism is associated with muscle fibre composition, athletic status and aerobic performance |
| Q30434317 | ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development |
| Q43800030 | AT(2) receptor-mediated vasodilation in the heart: effect of myocardial infarction |
| Q44490998 | AT1 and AT2 receptors in human glomerular endothelial cells at different passages |
| Q35047332 | AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR. |
| Q35777568 | Activation of central angiotensin type 2 receptors suppresses norepinephrine excretion and blood pressure in conscious rats |
| Q31805054 | Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation |
| Q35045801 | Angiotensin AT2 receptors: cardiovascular hope or hype? |
| Q40238417 | Angiotensin II Type 2-Receptor Agonist C21 Reduces Proteinuria and Oxidative Stress in Kidney of High-Salt-Fed Obese Zucker Rats |
| Q30426697 | Angiotensin II Type-2 receptors modulate inflammation through signal transducer and activator of transcription proteins 3 phosphorylation and TNFα production. |
| Q38206728 | Angiotensin II and vascular injury |
| Q53604633 | Angiotensin II causes cellular proliferation in infantile haemangioma via angiotensin II receptor 2 activation. |
| Q43257222 | Angiotensin II enhances hyperpolarization-activated currents in rat aortic baroreceptor neurons: involvement of superoxide |
| Q43797608 | Angiotensin II in cardiac pressure-overload hypertrophy in fetal sheep |
| Q35843514 | Angiotensin II increases connective tissue growth factor in the kidney. |
| Q33237419 | Angiotensin II production and distribution in the kidney--II. Model-based analysis of experimental data |
| Q83006787 | Angiotensin II production and distribution in the kidney: I. A kinetic model |
| Q38167346 | Angiotensin II receptor antagonists in acute coronary syndromes |
| Q36223169 | Angiotensin II receptor blockade and ventricular remodelling |
| Q34496676 | Angiotensin II receptors and drug discovery in cardiovascular disease |
| Q28564493 | Angiotensin II type 1 receptor blocker preserves tolerance to ischemia-reperfusion injury in Dahl salt-sensitive rat heart |
| Q37986143 | Angiotensin II type 2 receptor agonists: where should they be applied? |
| Q47242663 | Angiotensin II type 2 receptor inhibits expression and function of insulin receptor in rat renal proximal tubule cells. |
| Q40851849 | Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation |
| Q28573451 | Angiotensin II's antiproliferative effects mediated through AT2-receptors depend on down-regulation of SM-20 |
| Q34555180 | Angiotensin II-mediated signal transduction pathways. |
| Q38803664 | Angiotensin III increases monocyte chemoattractant protein-1 expression in cultured human proximal tubular epithelial cells |
| Q34268762 | Angiotensin and its AT2 receptor: new insights into an old system |
| Q35885203 | Angiotensin converting enzyme inhibition for cardiac hypertrophy in patients with end-stage renal disease: what is the evidence? |
| Q46525969 | Angiotensin receptor blockers suppress antigen-specific T cell responses and ameliorate collagen-induced arthritis in mice |
| Q35876800 | Angiotensin-II mediates nonmuscle myosin II activation and expression and contributes to human keloid disease progression |
| Q42078470 | Apoptosis after reperfused myocardial infarction: Role of angiotensin II. |
| Q57085383 | Are Retinal Microvascular Phenotypes Associated With the 1675G/A Polymorphism in the Angiotensin II Type-2 Receptor Gene? |
| Q35838481 | Are angiotensin receptor blockers neuroprotective? |
| Q37362745 | Atrial fibrillation and renin-angiotensin system |
| Q27346365 | Attenuation of ligand-induced activation of angiotensin II type 1 receptor signaling by the type 2 receptor via protein kinase C. |
| Q44068511 | Cardiac modulations of ANG II receptor expression in rats with hypoxic pulmonary hypertension. |
| Q33844005 | Cardiac phenotype and angiotensin II levels in AT1a, AT1b, and AT2 receptor single, double, and triple knockouts |
| Q36477635 | Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2 |
| Q54610810 | Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK. |
| Q37595599 | Cardiovascular effects of losartan and its relevant clinical application |
| Q83694338 | Cellular and RAS changes in the hearts of young obese rats |
| Q45102837 | Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors |
| Q33881270 | Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats |
| Q45063927 | Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunction |
| Q57395355 | Clinical implications of apoptosis in hypertensive heart disease |
| Q36596857 | Clinical trial update: focus on the ONTARGET study |
| Q44230612 | Comparison of the antagonistic effects of different angiotensin II receptor blockers in human coronary arteries |
| Q45292475 | Comparison of the effects of quinapril and losartan on carotid artery intima-media thickness in patients with mild-to-moderate arterial hypertension |
| Q51819142 | Constitutively active homo-oligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stimulation. |
| Q24310775 | Deficiency of intrarenal angiotensin II type 2 receptor impairs paired homeo box-2 and N-myc expression during nephrogenesis |
| Q35063290 | Di-acidic motifs in the membrane-distal C termini modulate the transport of angiotensin II receptors from the endoplasmic reticulum to the cell surface |
| Q37193753 | Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes |
| Q44618161 | Dietary salt intake modulates progression of antithymocyte serum nephritis through alteration of glomerular angiotensin II receptor expression |
| Q28344420 | Differential effect of angiotensin II on blood circulation in the renal medulla and cortex of anaesthetised rats |
| Q28569728 | Differential effects of 17beta-estradiol and of synthetic progestins on aldosterone-salt-induced kidney disease |
| Q35046246 | Differential regulation by AT(1) and AT(2) receptors of angiotensin II-stimulated cyclic GMP production in rat uterine artery and aorta. |
| Q44353130 | Down-regulation of bradykinin B2-receptor mRNA in the heart in pressure-overload cardiac hypertrophy in the rat. |
| Q36724656 | Drug discovery for heart failure: a new era or the end of the pipeline? |
| Q44739752 | Effect of angiotensin II type 2 receptor blockade on activation of mitogen-activated protein kinases after ischemia-reperfusion in isolated working rat hearts |
| Q47928468 | Effect of angiotensin II type 2 receptor blockade on mitogen activated protein kinases during myocardial ischemia-reperfusion |
| Q43754711 | Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction |
| Q73189494 | Effects of the AT1 receptor antagonist on adhesion molecule expression in leukocytes and brain microvessels of stroke-prone spontaneously hypertensive rats |
| Q51286274 | Effects of the Antihypertensive Fixed-Dose Combinations on an Early Marker of Hypertensive Cardiac Damage in Subjects at Low Cardiovascular Risk. |
| Q44838500 | Elevated blood pressure in normotensive rats produced by 'knockdown' of the angiotensin type 2 receptor |
| Q40431943 | Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload |
| Q33601928 | Expression and distribution of NADPH oxidase isoforms in human myometrium--role in angiotensin II-induced hypertrophy. |
| Q64038810 | Expression of angiotensin type II receptor downregulates Cdk4 synthesis and inhibits cell-cycle progression |
| Q36925629 | Expression of renin-angiotensin system components in the early bovine embryo |
| Q36287926 | Extracellular matrix and growth factors during heart growth. |
| Q53228641 | Farnesoid X receptor regulates vasoreactivity via Angiotensin II type 2 receptor and the kallikrein-kinin system in vascular endothelial cells. |
| Q34485828 | Foetal hypoxia increases cardiac AT(2)R expression and subsequent vulnerability to adult ischaemic injury. |
| Q34266992 | Glucocorticoid modulates angiotensin II receptor expression patterns and protects the heart from ischemia and reperfusion injury. |
| Q35672941 | HIV-associated nephropathy: role of AT2R. |
| Q35835330 | Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma |
| Q46663979 | Immunolocalization of ACE2 and AT2 receptors in rabbit atherosclerotic plaques. |
| Q37867324 | Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy |
| Q73782374 | Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation |
| Q35099157 | Inflammation and angiotensin II. |
| Q21285095 | Influence of mast cells in drug-induced gingival overgrowth |
| Q37067643 | Inhibiting the renin-angiotensin system with ACE Inhibitors or ARBs after MI. |
| Q30444722 | Interaction between bradykinin subtype 2 and angiotensin II type 2 receptors during post-MI left ventricular remodeling |
| Q48638828 | Interference of angiotensin II and enalapril with hepatic blood flow regulation. |
| Q35383835 | International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides. |
| Q55506567 | Jak2 Tyrosine Kinase: A Potential Therapeutic Target for AT1 Receptor Mediated Cardiovascular Disease. |
| Q34731369 | Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis |
| Q73318406 | Lipopolysaccharides and cytokines downregulate the angiotensin II type 2 receptor in rat cardiac fibroblasts |
| Q43050349 | Long-term effects of telmisartan on blood pressure, the renin-angiotensin-aldosterone system, and lipids in hypertensive patients |
| Q37595616 | Losartan chemistry and its effects via AT1 mechanisms in the kidney |
| Q36407240 | Manipulating the angiotensin system--new approaches to the treatment of solid tumours |
| Q44356539 | Maternal High-Fat Diet Causes a Sex-Dependent Increase in AGTR2 Expression and Cardiac Dysfunction in Adult Male Rat Offspring |
| Q53208117 | May the fibrosis be with you: Is discoidin domain receptor 2 the receptor we have been looking for? |
| Q44298472 | Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit |
| Q36748599 | Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury |
| Q33194991 | Molecular cloning, characterization, and distribution of the gerbil angiotensin II AT2 receptor |
| Q38780883 | Myocardial reverse remodeling: how far can we rewind? |
| Q34963358 | Nitric oxide and cardioprotection during ischemia-reperfusion |
| Q35090355 | Nitric oxide and cardiovascular protection |
| Q38045751 | Non-genomic effect of glucocorticoids on cardiovascular system |
| Q46644571 | Oligohydramnios and pulmonary hypoplasia: a case in which involvement of an angiotensin II receptor antagonist was suspected |
| Q30830224 | Ontogeny and regulation of the AT1 and AT2 receptors in the ovine fetal adrenal gland |
| Q52085091 | Ontogeny of vascular growth factors in perinatal sheep myocardium. |
| Q54559171 | PDGF-β receptor and PKC have no effect on angiotensin II-induced JAK2 and STAT1 phosphorylation in vascular smooth muscle cells under high glucose condition. |
| Q28073856 | Pathobiology of wound healing after glaucoma filtration surgery |
| Q43562117 | Perinatal dietary NaCl level: effect on angiotensin-induced thermal and dipsogenic responses in adult rats |
| Q36737671 | Perindopril versus angiotensin II receptor blockade in hypertension and coronary artery disease: implications of clinical trials |
| Q35074218 | Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders. |
| Q27341905 | Preconditioning via angiotensin type 2 receptor activation improves therapeutic efficacy of bone marrow mononuclear cells for cardiac repair |
| Q46563865 | Proinflammatory role of angiotensin II in a rat nephrosis model induced by adriamycin |
| Q34256543 | Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2. |
| Q48251701 | Protective effects of tannic acid on pressure overload-induced cardiac hypertrophy and underlying mechanisms in rats. |
| Q39862510 | Rab1 GTPase and dimerization in the cell surface expression of angiotensin II type 2 receptor |
| Q34773585 | Rab1 GTPase regulates phenotypic modulation of pulmonary artery smooth muscle cells by mediating the transport of angiotensin II type 1 receptor under hypoxia |
| Q35880186 | Reactive Oxygen Species and Nuclear Factor Erythroid 2-Related Factor 2 Activation in Diabetic Nephropathy: A Hidden Target |
| Q35748228 | Redox regulation of angiotensin II signaling in the heart. |
| Q34273837 | Regulation of GPCR signaling in hypertension |
| Q34028447 | Regulation of matrix proteins and impact on vascular structure |
| Q40536187 | Regulation of the cell surface expression and function of angiotensin II type 1 receptor by Rab1-mediated endoplasmic reticulum-to-Golgi transport in cardiac myocytes. |
| Q36067015 | Regulation of therapeutic apoptosis: a potential target in controlling hypertensive organ damage |
| Q50665394 | Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis. |
| Q34417331 | Renal fibrosis. |
| Q28363418 | Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice: role of endothelin-1 |
| Q46526091 | Renoprotective effect of benazepril on diabetic nephropathy mediated by P42/44MAPK. |
| Q37094334 | Role of angiotensin II receptor subtypes in porcine basilar artery: functional, radioligand binding, and cell culture studies |
| Q37739210 | Role of the angiotensin II receptor blocker valsartan in heart failure. |
| Q35099147 | Skeletal muscle RAS and exercise performance |
| Q44703364 | Specific MAP-kinase blockade protects against renal damage in homozygous TGR(mRen2)27 rats |
| Q35657292 | Summertime dosage-dependent hypersensitivity to an angiotensin II receptor blocker |
| Q28364369 | Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors |
| Q37368101 | Target-organ protection with combination renin-angiotensin-system blockade. |
| Q81045137 | Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials |
| Q40250332 | Telmisartan aggravates pustular psoriasis |
| Q43036719 | Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy |
| Q44183049 | The ERK pathway regulates Na(+)-HCO(3)(-) cotransport activity in adult rat cardiomyocytes. |
| Q37150747 | The Frail Renin-Angiotensin System |
| Q90633540 | The Glucocorticoid Receptor in Cardiovascular Health and Disease |
| Q52851745 | The actions of relaxin on the human cardiovascular system. |
| Q37622575 | The angiotensin II type 2 receptor in cardiovascular disease |
| Q37622566 | The angiotensin II type 2 receptor in renal disease |
| Q34135967 | The differential effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers with respect to foot ulcer and limb amputation in those with diabetes |
| Q36024882 | The effects of Ins2(Akita) diabetes and chronic angiotensin II infusion on cystometric properties in mice |
| Q36288155 | The extracellular matrix and the cytoskeleton in heart hypertrophy and failure |
| Q35226462 | The kallikrein-kinin system in diabetic retinopathy |
| Q35689005 | The pathogenesis of fibrosis and renal disease in scleroderma: recent insights from glomerulosclerosis |
| Q36421051 | The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension |
| Q38011656 | The role of angiotensin receptor blockers in reducing the risk of cardiovascular disease |
| Q34836065 | The role of reactive oxygen species in microvascular remodeling |
| Q34481715 | Therapeutic potential of angiotensin II receptor antagonists |
| Q37609631 | Thyroid hormone and atherosclerosis |
| Q35099152 | Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system |
| Q34101139 | Transgenic mouse models of angiotensin receptor subtype function in the cardiovascular system |
| Q46798949 | Type 1 angiotensin receptor (AT1-R)-mediated decrease in type 2 angiotensin receptor mRNA level is dependent on Gq and extracellular signal-regulated kinase 1//2 in AT1-R-transfected PC12 cells |
| Q35810247 | Up-regulation of AT(1) and AT(2) receptors in postinfarcted hypertrophied myocytes and stretch-mediated apoptotic cell death |
| Q38066000 | Update on the angiotensin AT(2) receptor. |
| Q35609704 | Valsartan for the treatment of heart failure |
| Q37247141 | Vascular Smooth Muscle Cell Signaling Mechanisms for Contraction to Angiotensin II and Endothelin-1. |
| Q50937291 | Vascular angiotensin II type 2 receptor attenuates atherosclerosis via a kinin/NO-dependent mechanism. |
| Q28344910 | Vasoconstriction is determined by interstitial rather than circulating angiotensin II |
| Q81068259 | [Molecular biology of the heart atrium. New insights into the pathophysiology of atrial fibrillation as well as its clinical implications] |
Search more.